Æ«±½ÈýËáÈýÐÁõ¥(TOTM), ÒòÆäÁ¼ºÃµÄËÜ»¯ÐÔ¡¢ÄÍÇ¨ÒÆÐÔ¡¢Ä͸ßÎÂÒÔ¼°µÍ¶¾ÐÔ£¬±»ÈÏΪÊÇ¿ÉÌæ´úÁÚ±½¶þ¼×Ëá¶þ(2-ÒÒ»ù¼º»ù)õ¥(DEHP)µÄÒ»ÖÖÓÅÁ¼ÔöËܼÁ¡£¾¡¹ÜĿǰûÓгä·ÖÖ¤¾ÝÏÔʾҽÁÆÆ÷еÖÐTOTM¶ÔÈËÌåÓÐÏÔÖøµÄÓ°Ï죬¿ÉÊÇ£¬¶¯ÎïʵÑé±êÃ÷TOTMÔÚ´úлµÄÀú³ÌÖлá»ýÀÛÔÚ×éÖ¯Àï¡£¿¼²ìTOTMµÄÈܳöÁ¿µÄÓ°ÏìÒòËØÒÔ¼°ÈËÌå¿É½ÓÊܵÄÄÍÊÜÏÞÁ¿£¬ÌرðÊÇһЩÐÂÉú¶ù¡¢ÓÐÉí»ò²¸È鸾ŮµÈ¸ßÃô¸ÐȺÌåÊÇÊ®·ÖÐëÒªµÄ¡£½ÓÄÉGC-MS 6800ÆøÏàÉ«Æ×ÖÊÆ×ÁªÓÃÒÇ£¬¶ÔÒ½ÁÆÆ÷еPVCÖÐTOTM½øÐÐ¼à¿Ø£¬»ñµÃÁ˱ȽÏÂúÒâµÄ²âÊÔЧ¹û¡£
1.ÒÇÆ÷¼ò½é
GC-MS 6800ÊÇÃÀʨ¹ó±ö»áÒÇÆ÷¾«ÐÄ´òÔìµÄÒ»¿î¸ßÐÔ¼Û±ÈÆøÏàÉ«Æ×ÖÊÆ×ÁªÓÃÒÇ£¬¾ßÓÐÍêÈ«µÄ×ÔÖ÷֪ʶ²úȨ£¬ÓµÓжàÏîרÀû¼¼Êõ£¬¿É¹ã·ºÓ¦ÓÃÓڸ߷Ö×ÓÖÊÁÏ¡¢Çé¿ö±£»¤¡¢µç×ÓµçÆ÷¡¢Ò½Ò©¡¢Ê¯ÓÍ»¯¹¤¡¢Ê³Æ·Äþ¾²¡¢·Ä֯Ƥ¸ïµÈ¶àÐÐÒµÖÐÓк¦ÎïÖʵļì²â¡£

ͼ1.GC-MS 6800ÆøÏàÉ«Æ×ÖÊÆ×ÁªÓÃÒÇÍâ¹Ûͼ
2.ʵÑ鲿·Ö
2.1 ²âÊÔÔÀí
ÑùÆ·¾¼ôËéºó׼ȷ³ÆÈ¡£¬¾ÒÒËáÒÒõ¥ÝÍÈ¡¹ýÂ˺ó£¬ÓÃGCMSÆÊÎö¡£ÒÀ¾ÝÄ¿±ê»¯ºÏÎïµÄ±£´æÊ±¼äºÍ±ê×¼ÖÊÆ×ͼ»òÌØÕ÷Àë×Ó¶¨ÐÔ£¬ÓÃÍâ±ê·¨¶¨Á¿¡£
2.2Ö÷ÒªÒÇÆ÷É豸¡¢ºÄ²ÄºÍÊÔ¼Á
GC-MS 6800 ÆøÏàÉ«Æ×ÖÊÆ×ÁªÓÃÒÇ£¬ÅäÓÐEI£¨ÃÀʨ¹ó±ö»á£©£»
ÆÊÎöÌìÆ½£º¾«¶ÈÊ®Íò·ÖÖ®Ò»£¨BT 125D£¬Èü¶àÀû˹¿ÆÑ§ÒÇÆ÷£¨±±¾©£©ÓÐÏÞ¹«Ë¾£©£»
Æ«±½ÈýËáÈýÐÁõ¥£¨TOTM£©±ê׼Ʒ£º¦Ñ=1000mg/L £¨¹ú¼Ò±ê×¼ÎïÖÊÍø£©£»
ÒÒËáÒÒõ¥£ºHPLC¼¶£¨Ä¬¿Ë£©¡£
Õý¼ºÍ飺HPLC¼¶£¨Ä¬¿Ë£©¡£
2.2 ÒÇÆ÷²âÊÔÌõ¼þ
É«Æ×Öù£ºDB-5MS£¬15m¡Á0.25mm¡Á0.1¦Ìm£»
ÖùÏä³ÌÐòÉýÎÂÌõ¼þ£º³õʼζÈ100¡æ£¬20¡æ/minÉýÖÁ280¡æ¼á³Ö6min£»
½øÑù·½·¨£º²»·ÖÁ÷½øÑù£¬²»·ÖÁ÷ʱ¼ä1min£¬·ÖÁ÷±È20:1£»
½øÑùÁ¿£º1.0¦ÌL£»
½øÑù¿Úζȣº280¡æ£»
ÆøÖʽӿÚζȣº280¡æ£»
Àë×ÓԴζȣº280¡æ£»
ÔØÆø£ºº¤Æø£¬´¿¶È¡Ý99.999%£¬Á÷ËÙ1.0mL/min£»
µçÀë·½·¨£ºEI£»
µçÀëÄÜÁ¿£º70eV£»
ÈܼÁÇгýʱ¼ä£º4min£»
²â¶¨·½·¨£ºTIC£¨FULL SCAN£©¶¨ÐÔ£¨É¨Ãè¹æÄ££º45-450amu£©£¬SIMģʽ¶¨Á¿¡£
3.²âÊÔ½á¹û
3.1 TOTM±ê×¼ÎïÖÊ×é·Ö¶¨ÐÔ½á¹û
1.TOTM
ͼ2. TOTM±ê×¼ÎïÖÊ×ÜÀë×ÓÁ÷É«Æ×ͼ
ͼ3.TOTMÖÊÆ×ͼ
±í1.Ä¿±êÎï»ù±¾²âÊÔÐÅÏ¢
|
»¯ºÏÎï
|
Ó¢ÎÄÃû³Æ
|
CASºÅ
|
ÌØÕ÷Àë×Ó
|
|
Æ«±½ÈýËáÈýÐÁõ¥
|
TOTM
|
3319-31-1
|
350* 306 323 193
|
3.2 ÑùÆ·²âÊÔ
ͼ4.ʵ¼ÊÑùÆ·²âÊÔͼ
4.×ܽá
±¾ÊµÑé½ÓÄÉÆøÏàÉ«Æ×ÖÊÆ×ÁªÓ÷¨£¨GC-MS£©£¬ÔÚSIMɨÃèģʽ϶ÔÒ½ÁÆÆ÷еÖÐTOTM½øÐж¨ÐÔ¶¨Á¿²âÊÔ£¬ÒªÁìÎȶ¨¿É¿¿£¬ÏßÐÔ¹æÄ£ºÃ£¬ÁéÃô¶È¸ß£¬ÊÜÔÓÖÊ·å×ÌÈÅС£¬ÍêÈ«ÇкϲâÊÔÒªÇó¡£
5£®²Î¿¼ÎÄÏ×
[1] HG/T 3874-2018 ¹¤ÒµÆ«±½ÈýËáÈý£¨2-ÒÒ»ù¼º»ù£©õ¥£¨TOTM£©
[2] GB/T 16886.17-2005 Ò½ÁÆÆ÷еÉúÎïѧÆÀ¼Û µÚ17²¿·Ö£º¿ÉÁ¤ÂËÎïÔÊÐíÏÞÁ¿µÄ½¨Á¢
[3] IS0 10993-17:2002 Biological
evaluation of medical devices ¨C Part 17: Establishment of allowable limits for
leachable substances